Shiqi Ren
Research Subjects
Shiqi Ren has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Anqi Lin
Department of Oncology Zhujiang Hospital, The First School of Clinical Medicine, Southern Medical University; Donghai County People's Hospital (Affiliated Kangda College of Nanjing Medical University) Lianyungang China
1 shared publication Chengfeng Guo
Nantong University Medical School, Nantong, Jiangsu, 226001, China
1 shared publication- Chengming Sun
Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China; Department of Hand Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
1 shared publication - Chenlin Zhang
Department of Orthopaedics, Qidong Hospital of Chinese Medicine, Nantong, China
1 shared publication Chudi Sun
School of Computer Science and Technology Soochow University Suzhou Jiangsu China
1 shared publicationDanyang Shen
Department of General Surgery The First Affiliated Hospital of Soochow University Suzhou Jiangsu China
1 shared publication
Latest Publications
- Open Access
Medical Data as a Key Asset in the Digital Health Era: A Framework for Challenges and Strategies
In the digital health era, medical data is key to personalized medicine and population health management, but its sharing and use face challenges—making a Medical Data Element Ecosystem (MDEE) essential to unlock its full potential. This study reviews literature to compare international frameworks with Chinese initiatives and examines cases like medical consortia and cross‐border platforms. We propose the MDEE practical framework, covering micro‐level stakeholder roles/responsibilities and macro‐level progress in technological innovation, institutional reforms, and ethical governance. It identifies China's key priorities: construction of federated systems, talent and capacity building, ethical framework development, global standard participation, and digital equity assurance. The MDEE practical framework offers an integrated approach from operational to strategic levels. In addition, building this ecosystem needs managing three key relationships: multi‐stakeholder co‐creation, integration of global best practices with local innovation, and balancing data protection with innovation. By addressing these issues, China could work toward developing an MDEE that promotes data security, efficient circulation, fair value distribution, and sustainable development, potentially maximizing the value of medical data.
Open AccessMedical Data as a Key Asset in the Digital Health Era: A Framework for Challenges and Strategies
In the digital health era, medical data is key to personalized medicine and population health management, but its sharing and use face challenges—making a Medical Data Element Ecosystem (MDEE) essential to unlock its full potential. This study reviews literature to compare international frameworks with Chinese initiatives and examines cases like medical consortia and cross‐border platforms. We propose the MDEE practical framework, covering micro‐level stakeholder roles/responsibilities and macro‐level progress in technological innovation, institutional reforms, and ethical governance. It identifies China's key priorities: construction of federated systems, talent and capacity building, ethical framework development, global standard participation, and digital equity assurance. The MDEE practical framework offers an integrated approach from operational to strategic levels. In addition, building this ecosystem needs managing three key relationships: multi‐stakeholder co‐creation, integration of global best practices with local innovation, and balancing data protection with innovation. By addressing these issues, China could work toward developing an MDEE that promotes data security, efficient circulation, fair value distribution, and sustainable development, potentially maximizing the value of medical data.
- Open Access
- 11 August 2025
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (2) , 354-367
Identification and validation of TUBB, CLTA, and FBXL5 as potential diagnostic markers of postmenopausal osteoporosis
Postmenopausal osteoporosis (PMOP) is recognized as the most prevalent bone disease worldwide. N6-methyladenosine (m6A) is one of the most common RNA modifications influencing the progression of various disorders; however, its specific role in PMOP remains unexplored. This study aims to investigate the expression profiles of m6A-related genes and their impact on the prognosis of PMOP patients. We utilized the GSE56815 expression analysis dataset obtained from the Gene Expression Omnibus (GEO) database and extracted m6A-related genes for further examination. Our analysis revealed that m6A-related genes exhibited differential expression between PMOP patients and healthy controls. We employed consensus clustering to identify subgroups within the PMOP cohort and conducted immunological analyses on these clusters. Additionally, we intersected the clusters to identify differentially expressed genes (DEGs) and analyzed potential diagnostic markers for PMOP using support vector machine recursive feature elimination (SVM-RFE), LASSO, and random forest (RF) algorithms, which were subsequently validated in the GSE56116 dataset. The receiver operating characteristic (ROC) curve was employed to assess the diagnostic significance of these markers. Furthermore, quantitative PCR (qPCR) was performed to validate the expression of the identified genes. In the GSE56815 dataset, we identified three subtypes associated with m6A modifications, leading to the identification of 302 shared DEGs among these subtypes. Gene ontology (GO) analysis indicated that the DEGs were predominantly enriched in nuclear specks, the nuclear envelope, and nucleocytoplasmic transport processes. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis further revealed that DEGs were primarily associated with endocytosis and nucleocytoplasmic transport pathways. Through the application of SVM, LASSO, and RF algorithms, we identified three potential diagnostic markers: TUBB, CLTA, and FBXL5, which demonstrated promising diagnostic capabilities when tested against an independent dataset. qPCR validation confirmed significant expression differences of these genes between the control and PMOP groups. The genetic markers identified in this study hold potential for accurately predicting the risk of PMOP in patients. The findings contribute to understanding the underlying molecular mechanisms of CLTA, TUBB, and FBXL5 in PMOP and may facilitate the development of novel therapeutic strategies and improved monitoring of the disease.
- 11 August 2025
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (2) , 354-367
Open AccessIdentification and validation of TUBB, CLTA, and FBXL5 as potential diagnostic markers of postmenopausal osteoporosis
Postmenopausal osteoporosis (PMOP) is recognized as the most prevalent bone disease worldwide. N6-methyladenosine (m6A) is one of the most common RNA modifications influencing the progression of various disorders; however, its specific role in PMOP remains unexplored. This study aims to investigate the expression profiles of m6A-related genes and their impact on the prognosis of PMOP patients. We utilized the GSE56815 expression analysis dataset obtained from the Gene Expression Omnibus (GEO) database and extracted m6A-related genes for further examination. Our analysis revealed that m6A-related genes exhibited differential expression between PMOP patients and healthy controls. We employed consensus clustering to identify subgroups within the PMOP cohort and conducted immunological analyses on these clusters. Additionally, we intersected the clusters to identify differentially expressed genes (DEGs) and analyzed potential diagnostic markers for PMOP using support vector machine recursive feature elimination (SVM-RFE), LASSO, and random forest (RF) algorithms, which were subsequently validated in the GSE56116 dataset. The receiver operating characteristic (ROC) curve was employed to assess the diagnostic significance of these markers. Furthermore, quantitative PCR (qPCR) was performed to validate the expression of the identified genes. In the GSE56815 dataset, we identified three subtypes associated with m6A modifications, leading to the identification of 302 shared DEGs among these subtypes. Gene ontology (GO) analysis indicated that the DEGs were predominantly enriched in nuclear specks, the nuclear envelope, and nucleocytoplasmic transport processes. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis further revealed that DEGs were primarily associated with endocytosis and nucleocytoplasmic transport pathways. Through the application of SVM, LASSO, and RF algorithms, we identified three potential diagnostic markers: TUBB, CLTA, and FBXL5, which demonstrated promising diagnostic capabilities when tested against an independent dataset. qPCR validation confirmed significant expression differences of these genes between the control and PMOP groups. The genetic markers identified in this study hold potential for accurately predicting the risk of PMOP in patients. The findings contribute to understanding the underlying molecular mechanisms of CLTA, TUBB, and FBXL5 in PMOP and may facilitate the development of novel therapeutic strategies and improved monitoring of the disease.